Milestone Pharmaceuticals Inc.

NASDAQ:MIST

1.2 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -41.519-59.685-58.388-42.853-49.967-55.229-23.185-8.086
Depreciation & Amortization 0.1050.0920.0890.0930.0970.0380.010.008
Deferred Income Tax 000-7.269-5.53-1.63400
Stock Based Compensation 5.7769.5349.0487.2794.9451.1910.6330.19
Change In Working Capital 3.6561.243-3.2622.257-5.8072.8481.496-0.164
Accounts Receivables 1.460-0.730.465-0.112-0.169-0.1340.147
Inventory 000.73-0.4650.1120.16900
Accounts Payables 0.8750-0.9070.637-2.0833.522.876-0.222
Other Working Capital 1.3211.243-2.3551.62-3.724-0.672-1.380.058
Other Non Cash Items 3.1342.3920.0447.2695.531.6340.7870.059
Operating Cash Flow -28.848-46.424-52.469-33.224-50.732-51.152-21.046-8.052
Investing Activities:
Investments In Property Plant And Equipment 0-0.112-0.27200-0.413-0.005-0.036
Acquisitions Net 0086.1240035.41300
Purchases Of Investments 0-137.132-85.852-15-90-35-3.029-16.032
Sales Maturities Of Investments 121.8714229852035.02919.0320.045
Other Investing Activites -113.5870-86.12470-70-35.41316.003-15.987
Investing Cash Flow 8.2834.756-57.12470-70-0.38415.998-16.023
Financing Activities:
Debt Repayment 050000000
Common Stock Issued 27.2580.5742.635.05524.91785.36380.11530.722
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 4.861-2.2080.4585.05548.3070.04480.11530.722
Financing Cash Flow 32.11947.7923.0885.05573.22485.40780.11530.722
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 11.5546.124-106.50541.831-47.50833.87175.0676.647
Cash At End Of Period 25.31413.767.636114.14172.31119.81885.94710.88